What does a positive ATM gene mutation with ICD‑10 codes Z15.01 (genetic susceptibility to malignant neoplasm of breast) and Z15.09 (other genetic susceptibility to malignant neoplasm) indicate?

ATM Gene Mutation Positive: What It Means

A positive ATM gene mutation (indicated by ICD-10 codes Z15.01 and Z15.09) means you carry one abnormal copy of the ATM gene, which increases your risk of developing certain cancers—primarily breast cancer (2-3 fold increased risk), pancreatic cancer, and prostate cancer—and requires specific surveillance strategies based on individualized risk assessment. 1

Understanding Your Genetic Status

You are what's called an ATM heterozygote, meaning you have one normal and one mutated copy of the ATM gene. This is completely different from having ataxia-telangiectasia (AT), which only occurs when someone inherits two mutated copies (one from each parent). You will not develop AT, but you do have moderately increased cancer risks. 1

Key Cancer Risks

Breast Cancer (for females):

• Your lifetime risk increases approximately 2-3 fold compared to the general population
• Some specific ATM variants (like c.7271T>G) carry even higher risks 1, 2
• Risk varies based on family history and other factors—not all ATM carriers have the same risk 1

Other Cancers:

• Pancreatic cancer: moderately increased risk
• Prostate cancer: increased risk, particularly relevant for males
• Ovarian cancer: modest association but insufficient data to support aggressive risk reduction 1

What You Need to Do Now

For Females with ATM Mutations:

Breast Surveillance:

• Use a personalized risk calculator (CanRisk model) to determine your specific surveillance plan 1
• Most ATM carriers will qualify for enhanced breast surveillance beyond standard population screening
• Some carriers will meet criteria for breast MRI based on their calculated risk and country-specific guidelines
• Risk-reducing mastectomy is NOT routinely recommended for ATM carriers, though it may be considered after individualized risk assessment and shared decision-making 1

Important caveat: Standard risk calculators like CanRisk may underestimate risk for certain high-risk ATM variants (such as c.7271T>G p.Val2424Gly), so discuss your specific variant with your genetics team 1

Ovarian Cancer:

• Routine risk-reducing salpingo-oophorectomy (removal of ovaries and fallopian tubes) is NOT recommended 1
• May consider if you have a strong family history of ovarian cancer or need gynecological surgery for other reasons 1

For Males with ATM Mutations:

Prostate Cancer Screening:

• Begin annual PSA testing at age 40 1
• This is earlier than standard population screening

For All ATM Carriers:

Pancreatic Cancer Surveillance:

• Should be considered, ideally as part of a clinical trial 1
• Discuss with your genetics team, especially if you have family history of pancreatic cancer

Family Planning Considerations:

• If you have a partner, they have approximately 1 in 200 chance of also being an ATM carrier
• If both partners are carriers, each pregnancy has a 1 in 4 (25%) chance of producing a child with ataxia-telangiectasia
• Partner testing should be offered before pregnancy, particularly if there's consanguinity or family history of AT 1

Cascade Testing:

• Your first-degree relatives (parents, siblings, children) have a 50% chance of carrying the same mutation
• They should be offered genetic testing to guide their own cancer surveillance 1

If You Develop Cancer

Radiation Therapy:

• Do NOT avoid or modify radiation therapy based on your ATM status 1
• Despite theoretical concerns about radiation sensitivity, current evidence does not support treatment modifications for ATM heterozygotes

Targeted Therapies:

• PARP inhibitors (like olaparib) are approved for some cancers with ATM mutations, but evidence for effectiveness is currently weak 1
• For breast cancer specifically, ATM mutations show limited response to PARP inhibitors 1

Common Pitfalls to Avoid

1. Don't assume your family history explains everything: ATM-related cancers show reduced penetrance, meaning many carriers have minimal or no family history of cancer 1

2. Don't pursue overly aggressive risk reduction: Unlike BRCA1/2 carriers, ATM carriers typically don't meet thresholds for prophylactic mastectomy or oophorectomy 1

3. Don't skip partner testing if planning pregnancy: The risk of having a child with AT is real and should be assessed 1

4. Don't use outdated risk models: Ensure your risk assessment uses current tools like CanRisk that incorporate ATM status 1

The ICD-10 Codes Explained

• Z15.01: Genetic susceptibility to malignant neoplasm of breast
• Z15.09: Genetic susceptibility to other malignant neoplasms

These codes document your increased cancer risk for insurance and medical record purposes, triggering appropriate surveillance protocols.